Feb 26 (Reuters) - Endo International PLC ENDP.O :
* ENDO REPORTS FOURTH-QUARTER AND FULL-YEAR 2019 FINANCIAL RESULTS
* Q4 ADJUSTED EARNINGS PER SHARE $0.74 FROM CONTINUING OPERATIONS
* Q4 LOSS PER SHARE $0.92 FROM CONTINUING OPERATIONS
* Q4 REVENUE $765 MILLION VERSUS REFINITIV IBES ESTIMATE OF $731.4 MILLION
* Q4 EARNINGS PER SHARE ESTIMATE $0.57 -- REFINITIV IBES DATA
* SEES 2020 TOTAL REVENUES TO BE BETWEEN $2.72 BILLION AND $2.92 BILLION
* SEES 2020 ADJUSTED DILUTED NET INCOME PER SHARE FROM CONTINUING OPERATIONS TO BE BETWEEN $2.15 AND $2.40
* ENDO INTERNATIONAL - 2020 GUIDANCE FOR ADJUSTED EARNINGS PER SHARE FROM CONTINUING OPERATIONS, ADJUSTED EBITDA & ADJUSTED OPERATING EXPENSES EXCLUDE OPIOID-RELATED LEGAL EXPENSES
* QTRLY BRANDED PHARMACEUTICALS REVENUES WERE $226 MILLION COMPARED TO $230 MILLION
* QTRLY SPECIALTY PRODUCTS REVENUES INCREASED 15% TO $149 MILLION
* FY2020 EARNINGS PER SHARE VIEW $2.25, REVENUE VIEW $2.90 BILLION -- REFINITIV IBES DATA